MSD Pharma acquires Takeda Pharma’s Dunboyne manufacturing facility
Category: #business  By Pranali Mehta  Date: 2020-08-11
  • share
  • Twitter
  • Facebook
  • LinkedIn
MSD Pharma acquires Takeda Pharma’s Dunboyne manufacturing facility

MSD Pharmaceuticals, a renowned global healthcare firm that provides innovative healthcare solutions, has reportedly announced that it has agreed to acquire the cutting-edge biologics plant of Takeda Pharmaceuticals, located in Dunboyne, Co Meath.

This acquisition agreement would bring the total MSD site numbers within Ireland to six. The company expects to retain all of the Dunboyne plant’s 200 employees as part of the latest acquisition. The enterprise claimed that it is conducting consultations with its staff and anticipates the process to complete by mid-September 2020.

MSD’s Sanat Chattopadhyay stated that the facility would support the commercialization of the company’s existing as well as future product pipeline. The exceptional talent of the existing Dunboyne team was an important determining factor that influenced the company’s decision to procure the facility.

Chattopadhyay also stated that the company looks forward to welcome its new colleagues into the MSD Ireland network, further building upon the considerable progress that has been made by them to date and realizing, together, the overall potential of the facility to benefit patients across Ireland and worldwide.

The $400 million facility was initially announced in 2016 by Shire, a renowned biotech company, before the firm was acquired by Takeda through a major acquisition deal in in 2018.

In January of 2020, Takeda Pharma announced its plan to divest in the Dunboyne facility after a strategic review of the enterprise’s global biologics production network, showed that manufacturing capacity offered by the Dunboyne plant would not be required any longer.

Site lead at Susan Hynes, Takeda Dunboyne Biologics stated that the announcement showcases MSD’s confidence in the plant, its culture, and capabilities. As the plant readies for its long-term future across Dunboyne, the facility looks forward to further consolidate the close bond the team has with local community.

IDA Ireland helped Takeda Pharma in marketing its Dunboyne facility to potential buyers since it announced its plans to divest in the facility.

Source credit: https://www.siliconrepublic.com/companies/msd-takeda-manufacturing-dunboyne

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

Saudi Arabia to recommence tourist visa provision by early 2021
Saudi Arabia to recommence tourist visa provision by early 2021
By Pranali Mehta

Post months of suspending travel in and out of the country, so as to ensure the prevention of the coronavirus spread amid enforcement of stringent government measures, Saudi Arabia now plans to resume tourist visas by the beginning of 2021.The announ...

Singapore seeking proposals for harbourcraft electrification
Singapore seeking proposals for harbourcraft electrification
By Pranali Mehta

The Singapore government, is reportedly looking for proposals for electrification of harborcrafts, small harbor boats, that typically use oil as fuel and operate only inside the country’s waters. These vessels are generally used to move a small...

Ecology becomes third building society to raise funding through CCDS
Ecology becomes third building society to raise funding through CCDS
By Pranali Mehta

Sustainable lender Ecology Building Society has managed to raise £3 million from Core Capital Deferred Shares (CCDS), making it the third and smallest building society to secure capital through this form of instrument.  Reportedly, Ecolog...